Back to search results
NCT03062748

Predicting Cardiometabolic Risk in Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs. Apnea/Hypopnea Index

Enrolling by Invitation
Not specifiedAges 18+Observational
Milton S. Hershey Medical Center
~196 participants
Updated 2026-04-23 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Presence of the metabolic syndrome
Measured over baseline
+2 more outcomes measured

Conditions

Obstructive Sleep Apnea

Explore related trials

Obstructive Sleep Apnea

Where it's being run

1 sites across 1 states
Pennsylvania1

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Mild to moderate OSA (5≤ AHI \<30)
BMI ≤ 45
Age ≥ 18
Men \& Women

Exclusion

AHI ≥ 30
BMI \>45
Current use of steroids or anti-inflammatory medication
Diagnosis of insulin dependent diabetes
Diagnosis of autoimmune disorder
Shiftwork
Current use of CPAP

What this trial measures

  • Presence of the metabolic syndromebaseline

    At least 3 of the following 5 risk factors must be met in order to have the metabolic syndrome: 1. Elevated waist measurement (≥102 cm for men or ≥89 cm for women) 2. Elevated triglycerides (≥150 mg/dL or use of medication) 3. Low HDL cholesterol (\<50 mg/dL for women or \<40 mg/dL for men or use of medication) 4. Elevated blood pressure (≥130 mmHg systolic or ≥ 85 mmHg diastolic or use of medication) 5. Elevated fasting blood sugar (≥100 mg/dL or use of medication) Source: https://www.nhlbi.nih.gov/health/health-topics/topics/ms

  • Obstructive Sleep Apneabaseline

    AHI from one night polysomnography

  • Markers of systemic inflammationbaseline

    CRP, IL-6, TNFa